FACIAL DYSTONIA, ESSENTIAL BLEPHAROSPASM AND HEMIFACIAL SPASM

被引:0
|
作者
HOLDS, JB
WHITE, GL
THIESE, SM
ANDERSON, RL
机构
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Movement disorders, or dyskinesias, in the facial region may be categorized in several ways. Dystonic movement disorders in the cranial-cervical region, including essential blepharospasm, Meige syndrome and spasmodic torticollis, are characterized by uncontrollable squeezing movements in the face and neck. These disorders typically present in the fifth and sixth decades of life. Essential blepharospasm is particularly debilitating, as the involuntary eyelid closure that accompanies this condition may result in functional blindness with an otherwise normal visual pathway. Hemifacial spasm is an intermittent, unilateral, spasmodic contraction of the muscles innervated by the facial nerve. This disorder usually presents in the third or fourth decade and has a different underlying pathophysiology than the dystonias. Botulinum A toxin therapy has largely supplanted surgical intervention in the treatment of essential blepharospasm and hemifacial spasm.
引用
收藏
页码:2113 / 2120
页数:8
相关论文
共 50 条
  • [1] Asynchronous blepharospasm, facial and cervical dystonia, and bilateral asynchronous hemifacial spasm
    Katz, Bradley J.
    Burroughs, John R.
    Anderson, Richard L.
    Bownds, Shannon
    McCann, John D.
    MOVEMENT DISORDERS, 2007, 22 (02) : 231 - 234
  • [2] Alleviating Maneuvers for Benign Essential Blepharospasm and Hemifacial Spasm
    Lee, Andrew G.
    Miller, Neil R.
    JAMA OPHTHALMOLOGY, 2016, 134 (11) : 1253 - 1254
  • [3] Botulinum toxin treatment of essential blepharospasm and hemifacial spasm
    Singer, M
    OPHTHALMOLOGY, 1996, 103 (03) : 348 - 348
  • [4] Blepharospasm and hemifacial spasm
    Dan R. Boghen
    Robert L. Lesser
    Current Treatment Options in Neurology, 2000, 2 (5) : 393 - 399
  • [5] Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm
    Karp, Barbara Illowsky
    Alter, Katharine
    SEMINARS IN NEUROLOGY, 2016, 36 (01) : 84 - 91
  • [6] Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin
    Winterhoff, J.
    Laskawi, R.
    HNO, 2012, 60 (06) : 479 - 483
  • [7] Relative absence of psychopathology in benign essential blepharospasm and hemifacial spasm
    Scheidt, CE
    Schuller, B
    Rayki, O
    Kommerell, G
    Deuschl, G
    NEUROLOGY, 1996, 47 (01) : 43 - 45
  • [8] Benign essential blepharospasm: Risk factors with reference to hemifacial spasm
    Hall, TA
    McGwin, G
    Searcey, K
    Xie, AY
    Hupp, SL
    Owsley, C
    Kline, LB
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2005, 25 (04) : 280 - 285
  • [9] Clinical study of patients with benign essential blepharospasm and hemifacial spasm
    Deshpande, Rahul Dinkar
    Kshirsagar, Pranjali
    Yadav, Sonal P.
    Dole, Kuldeep
    Bharucha, Khurshed
    Shetty, Rakesh
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (06) : 2625 - 2626
  • [10] THE MANAGEMENT OF BLEPHAROSPASM AND HEMIFACIAL SPASM
    ELSTON, JS
    JOURNAL OF NEUROLOGY, 1992, 239 (01) : 5 - 8